Graz neurologists report progress in early Alzheimer treatment

New advances can identify Alzheimer disease 15 to 20 years earlier and slow its progression, ORF reports. Neurologists at the Medical University of Graz have recorded positive experiences with treatments that can remove harmful protein deposits from the brain.

Between 130,000 and 170,000 people in Austria are affected by dementia, most commonly Alzheimer disease. World Alzheimer Day on Monday is highlighting progress in early detection and treatment.

According to Christian Enzinger, head of neurology at the Medical University of Graz, early treatment can slow the disease’s progression by about 40 percent over six to eight months. Treatment is limited to patients who do not face an increased risk of side effects.

Three-stage early detection process

People experiencing signs of forgetfulness should first consult their family doctor. If the suspicion is confirmed, they are referred to a neurologist for further examinations.

When there is a specific suspicion of Alzheimer disease, a blood test can identify three biomarkers. Enzinger said the test should not be used for everyone because its suitability depends on the clinical likelihood of the disease before testing. Otherwise, it could cause unnecessary concern or produce false-positive results.

If the findings support the diagnosis, the third stage is an expert centre, such as the university neurology clinic in Graz.

Enzinger does not confirm reports of a rising number of Alzheimer cases among younger people. He attributed those reports to improved early detection and greater awareness of the disease.